Press Releases - Exact Sciences
Nov 5, 2024 · News and events. Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts. View news and events
News and events | Exact Sciences
Nov 5, 2024 · How uncovering DNA’s secrets changed, well, everything. Best of the 2024 Cologuard Classic by Exact Sciences. New England Journal of Medicine Publishes the Science Powering the Next-Generation Cologuard Test. Get Off the Bench: Hoops-Themed Campaign Urges Colorectal Cancer Screening.
Cancer Prevention, Screening & Therapy Guidance | Exact Sciences
Explore Exact Sciences, a leading provider of tests for cancer prevention, early detection and screening, and therapy guidance.
Cologuard® test | Exact Sciences
Backed by strong science and robust clinical research in collaboration with Mayo Clinic, Cologuard® is a stool DNA-based colorectal cancer screening test for average-risk individuals who are 45 or older.
FDA Approves Exact Sciences’ Cologuard Plus Test
MADISON, Wis., Oct. 4, 2024-- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved the Cologuard Plus™ test, the company’s next …
New England Journal of Medicine Publishes Cologuard ... - Exact …
Mar 13, 2024 · The 20,000-participant BLUE-C study was designed to determine the performance characteristics of Exact Sciences’ next-generation multitarget stool DNA test, Cologuard Plus, for colorectal cancer (CRC) and to compare that performance to the fecal immunochemical test (FIT), a commonly used noninvasive CRC screening test.
News and events - Exact Sciences
Stay up to date with Exact Sciences’ news, announcements, patient stories, and events.
Exact Sciences Announces Third-Quarter 2024 Results
Nov 5, 2024 · Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Exact Sciences Advances Innovative Cancer Technologies and …
Jun 21, 2023 · Combining cutting-edge technologies with expertise from thought leaders at Broad Institute of MIT and Harvard and Baylor Scott & White, Exact Sciences will provide smarter answers before diagnosis and throughout cancer treatment.
Court Ruling Enables Exact Sciences to Proceed with Lawsuit …
On May 15, 2024, Exact Sciences filed a second complaint against Geneoscopy to defend its intellectual property against infringement in the United States District Court for the District of Delaware. The case asserts a new patent, the ’746 patent, …